NASDAQ: KRBPKiromic Biopharma Inc Stock Ownership - Who owns Kiromic Biopharma?
Insider buying vs selling
Have Kiromic Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when KRBP insiders and whales buy or sell their stock.
KRBP Shareholders
What type of owners hold Kiromic Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Internati Maurizio Chiriva | 226.58% | 1,378,072 | $6.05M | Insider |
| Pietro Bersani | 104.95% | 638,298 | $2.80M | Insider |
| Sabby Management LLC | 90.42% | 549,944 | $2.41M | Institution |
| Scott Dahlbeck | 81.67% | 496,757 | $2.18M | Insider |
| Tony Tontat | 66.09% | 402,000 | $1.76M | Insider |
| Gianluca Rotino | 52.61% | 320,000 | $1.40M | Insider |
| Zeke Capital Advisors LLC | 17.59% | 107,000 | $469.73k | Institution |
| Daniel Grant Clark | 10.32% | 62,770 | $275.56k | Insider |
| Michael Charles Ryan | 8.25% | 50,189 | $220.33k | Insider |
| Geode Capital Management LLC | 6.73% | 40,962 | $179.82k | Institution |
KRBP vs Biotech Stocks
Kiromic Biopharma Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.